Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06840834

1 development in the corpus

NCT06840834

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 2 TRIAL

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

ClinicalTrials.gov

This is a registered Phase 2 trial with no reported results; it is recruiting and has not yet generated outcome data.

PreliminaryIvonescimab Intergroupe Francophone de Cancerologie Thoracique Pleural Mesotheliomas

Reported

Planned enrollment38

PhasePhase 2

Primary outcome measureDisease control rate at 12 weeks after star…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support